CoJourney Inc. is a contract development and manufacturing organization (CDMO) focused on cell and gene therapies, offering end-to-end services for plasmids, viral vectors, and mRNA. The company operates a 130,000 square foot state-of-the-art cGMP manufacturing facility equipped with 500L and 2,000L disposable bioreactors for viral vectors and 30L disposable fermenters for plasmids. Its proprietary technology platform and scalable processes support process development, cGMP production, analytical method development, QC testing and release, banking, drug substance production, and drug product filling. CoJourney employs over 150 scientific and operations staff and its management team has more than 15 years of operational experience in cell and gene therapy manufacturing globally. The company reports a track record of delivering high-quality genetic medicines and has manufactured products approved by global regulatory agencies, including the US FDA, for use in clinical trials. CoJourney is expanding its US operations and commercial manufacturing capabilities to expedite production and serve clients from early development through clinical and commercial-scale manufacturing.

Total raised

$30M

Funding rounds

1

Latest round

Series A

Latest activity

Jul 2023